ASSESSMENT OF THE PATHOGENETIC SIGNIFICANCE OF AGE, GENDER AND OTHER RISK FACTORS IN THE DEVELOPMENT OF NEPHROPATHIES IN PATIENTS WITH OBESITY AND BRONCHIAL ASTHMA COMORBIDITY

Mirzayeva Maftuna Orifjon qizi

Authors

Mirzayeva Maftuna Orifjon qizi Bukhara state medical institute

Keywords:

bronchial asthma, obesity, nephropathy, chronic kidney disease, comorbidity, cystatin-C, NGAL.

Abstract

Obesity and bronchial asthma are common chronic diseases in modern medicine, which often occur as comorbidities. These pathologies negatively affect various organ systems, including the kidneys, through metabolic, immunological and inflammatory processes. Recent epidemiological studies show that patients with a combination of bronchial asthma and obesity have a high risk of developing chronic kidney disease and nephropathies [2,5]. This article analyzes the pathogenetic significance of age, gender and other risk factors in the development of nephropathies in patients with comorbidities of obesity and bronchial asthma.

References

Augustou E., Papagianni A. Obesity-Related Chronic Kidney Disease: From Diagnosis to Management. Nutrients. 2025;17(2):112-124. DOI:10.3390/nu17020112. PMID: 39452010. PMCID: PMC 11763674.

Bantulà M., Roca-Ferrer J., Arismendi E. Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation. Journal of Clinical Medicine. 2021;10(3):487. DOI:10.3390/jcm10030487. PMID:33535771. PMCID: PMC 7825135.

Evangelista LS, et al. Obesity and Chronic Kidney Disease in Population Studies. Biological Research for Nursing. 2018;20(3):270-277. DOI:10.1177/1099800417753850. PMID: 29320963. PMCID: PMC 5831002.

Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7 ):e 0158765. DOI:10.1371/journal.pone.0158765. PMID: 27383068. PMCID: PMC 4935718.

Huang HL, et al. Bronchial Asthma and Risk of Chronic Kidney Disease: A Population Study. Chinese Medical Journal. 2014;127(14):2580-2584. DOI:10.3760/cma.j.issn.0366-6999.20131431. PMID: 24885269. PMCID: PMC 4022436.

Inker LA, Schmid CH, Tighiouart H., et al. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. New England Journal of Medicine. 2012;367(1):20-29. DOI:10.1056/NEJMoa1114248. PMID: 22762315. PMCID: PMC 4126804.

Kovesdy CP, Furth SL, Zoccali C. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. World Journal of Nephrology. 2017;6(1):1-8. DOI:10.5527/ wjn.v6.i 1.1. PMID: 28293301. PMCID: PMC 5338707.

Levey AS, Coresh J., Tighiouart H., et al. GFR Estimation and CKD Classification. Kidney International Supplements. 2019;9(3 ):S 1-S150. DOI:10.1016/j.kisu.2019.02.001. PMID:31197258. PMCID: PMC 6597893.

Liu DW, et al. Persistent Asthma Increases the Risk of Chronic Kidney Disease. Chinese Medical Journal. 2013;126(21):4093-4099. PMID: 24229680.

Matsushita K., van der Velde M., Astor BC, et al. Association of Estimated GFR and Albuminuria with Mortality. The Lancet. 2010;375(9731):2073-2081. DOI:10.1016/S0140-6736(10)60674-5. PMID: 20483451. PMCID: PMC 3993088.

Muntner P., Winston J., Uribarri J., et al. Overweight, Obesity and Elevated Serum Cystatin C Levels. American Journal of Kidney Diseases. 2008;51(5):720-729. DOI:10.1053/j.ajkd.2007.11.021. PMID: 18371536. PMCID: PMC 3049932.

Serwin N., et al. Renal and Inflammation Markers – Renalase, Cystatin C and NGAL. Diagnostics. 2022;12(1):108. DOI:10.3390/diagnostics12010108. PMID:35050938. PMCID: PMC 8774569.

Shirsat P., et al. Obesity and Chronic Kidney Disease: Pathophysiological Mechanisms. Kidney and Dialysis. 2025;1(1):4-15. DOI:10.3390/kidneydialysis1010004.

Tandan M., et al. Prevalence and Determinants of Chronic Kidney Disease. Clinical Kidney Journal. 2025;18(3 ):sfaf 065. DOI:10.1093/ ckj /sfaf065. PMID: 40010211. PMCID: PMC 11932339.

Yim HE, Yoo KH Obesity and Chronic Kidney Disease. Clinical and Experimental Pediatrics. 2021;64(8):405-413. DOI:10.3345/cep.2021.00108. PMID:33892712. PMCID: PMC 8428656